Leyden Laboratories
Develops broadly protective antibody-based nasal sprays to prevent infection by influenza and other respiratory viruses
€40MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops broadly protective antibody-based nasal sprays to prevent infection by influenza and other respiratory viruses
Develops advanced 3D scanning probe metrology and inspection systems for semiconductor manufacturing
Pitching Invest-NL? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room